KANSAS CITY, Kan., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company developing and advancing a pipeline of next-generation pharmaceutical products utilizing ...

KANSAS CITY, Kan., Aug. 15, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: CING) The Board of Directors of Cingulate Inc. (“Cingulate”) announced that it has placed Chairman and Chief Executive Officer, Shane J.

Cingulate Inc. placed CEO and Chairman Shane Schaffer on administrative leave days after he was arrested and charged with felony aggravated domestic battery. Cingulate’s board put Schaffer on leave ...

This important study investigates the influence of the cingulate cortex on the development of the social vocalizations of marmoset monkeys by making bilateral lesions of this brain area in neonatal ...

A new, free online service uses complex math to generate unique 3D models. Meti•kumi is a well-known 3D designer that has produced dozens of fascinating 3D printable models offered online. Most of ...

Blink and you might have missed it. FATMAP is back! Well, sort of. As we already lamented here on POWDER, our favorite 3D mapping app FATMAP was shut off for good last fall after being acquired by ...

For years, doctors have sought ways to restore lost bodily functions. The earliest prosthetic limbs date back to ancient Egypt, but today’s modern upgrades involve high-tech actuators and even AI.

Cingulate Inc. submitted CTx-1301 Phase 3 safety data to the FDA, preparing for a Pre-NDA meeting on April 2, 2025. Cingulate Inc. announced the submission of Phase 3 safety data for its ADHD ...

We compute analytically the Green's and its gradient and product with linear functions on a triangle T in R3. Let x be an evaluation point, r(x,y) = |y-x| and Let h(x) be a linear function on the ...

Depression affects millions of people globally, with pharmacologic therapy a mainstay of treatment. Treatments have also included procedures, such as electroconvulsive therapy (ECT), and more recently ...

Cingulate secures a European patent for its ADHD treatment. The biopharma firm is committed to filing an NDA with the FDA. Cingulate stock opened about 110% up on Friday morning. Cingulate Inc (NASDAQ ...